FR5924M - - Google Patents

Info

Publication number
FR5924M
FR5924M FR57734A FR57734A FR5924M FR 5924 M FR5924 M FR 5924M FR 57734 A FR57734 A FR 57734A FR 57734 A FR57734 A FR 57734A FR 5924 M FR5924 M FR 5924M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR57734A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5924M publication Critical patent/FR5924M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR57734A 1965-04-15 1966-04-15 Expired FR5924M (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1632665 1965-04-15
GB5209465A GB1153424A (en) 1965-04-15 1965-04-15 Pharmaceutical Compositions

Publications (1)

Publication Number Publication Date
FR5924M true FR5924M (de) 1968-04-01

Family

ID=26251972

Family Applications (1)

Application Number Title Priority Date Filing Date
FR57734A Expired FR5924M (de) 1965-04-15 1966-04-15

Country Status (3)

Country Link
DE (1) DE1568759C3 (de)
FR (1) FR5924M (de)
GB (1) GB1153424A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935266A (en) * 1970-10-28 1976-01-27 Taiho Pharmaceutical Company, Limited N-substituted guanidino acid derivatives

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
US5599841A (en) * 1990-02-28 1997-02-04 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
CA2117282A1 (en) * 1991-11-22 1993-05-27 Ofer Lider Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them
EP0646573A1 (de) * 1993-09-30 1995-04-05 Hoechst Aktiengesellschaft Herstellung von geschützten und nicht geschützten Guanidino-substituierten Carbonsäure
TW300883B (de) * 1994-07-26 1997-03-21 Kao Corp
CA2231632C (en) * 1995-10-11 2004-01-20 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
FR2788275B1 (fr) * 1999-01-11 2002-06-14 Lipha ((aminoiminomethyl)amino) alcane carboxamides et leurs applications en therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935266A (en) * 1970-10-28 1976-01-27 Taiho Pharmaceutical Company, Limited N-substituted guanidino acid derivatives

Also Published As

Publication number Publication date
DE1568759B2 (de) 1980-06-12
DE1568759A1 (de) 1970-03-26
GB1153424A (en) 1969-05-29
DE1568759C3 (de) 1981-02-19

Similar Documents

Publication Publication Date Title
JPS4823300B1 (de)
JPS459948Y1 (de)
FR5924M (de)
CS159727B2 (de)
JPS419978Y1 (de)
FR5250M (de)
JPS4120068Y1 (de)
JPS472816Y1 (de)
JPS4122104Y1 (de)
JPS4218645Y1 (de)
JPS469980Y1 (de)
BE671506A (de)
BE673298A (de)
NL6608407A (de)
NL6606880A (de)
BE672602A (de)
NL6600653A (de)
BE673504A (de)
BE672185A (de)
LU49994A1 (de)
BE672693A (de)
BE672318A (de)
BE672918A (de)
BE672013A (de)
BE673044A (de)